Steve Kelly

A phase II study of afatinib (BIBW 2992), an irreversible ErbB family blocker, in patients with HER2-positive metastatic breast cancer progressing after trastuzumab

Nancy U. Lin, Eric P. Winer, Duncan Wheatley et al. · Breast Cancer Research and Treatment · 2012 · 194 citations · Full text

Medicine, Oncology, Pharmacology +17

Tumour inoculation during laparoscopy

N. O’Rourke, P. Price, Steve Kelly et al. · The Lancet · 1993 · 142 citations

Medicine, Oncology, Surgery +3

Radiation pneumonitis in patients treated for breast cancer

R.I. Rothwell, Steve Kelly, C. A. Joslin · Radiotherapy and Oncology · 1985 · 121 citations

Medicine, Oncology, Radiation Oncology +14

Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication

David Miles, Eva Ciruelos, Fabio Puglisi et al. · Annals of Oncology · 2021 · 89 citations · Full text

Medicine, Oncology, Pharmacology +17

Palliation of obstructive nephropathy due to malignancy

Kevin J. Harrington, Hardev Pandha, Steve Kelly et al. · British Journal of Urology · 1995 · 44 citations

Medicine, Surgery, Urology +12